Clinical Trial Update: Phase 2 Estimation Study of Fixed Dose Drugs Combination Type of Polypill [Phase 2]

View source ↗

Summary

A Phase 2 estimation study of a fixed-dose drug combination polypill for Alzheimer's disease has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Fixed-dose polypill combination

Snippet

Sponsor: Noah Pharmaceuticals, Inc. | Conditions: Alzheimer Disease | Phase 2 | Status: COMPLETED